ROYAL BANK OF CANADA

Bank

Position in CUE — Cue Biopharma, Inc.

CIK 1000275 TORONTO, A6

Position in CUE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$63

+$46 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 49 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,242 across 427 Biotechnology names. CUE ranks #401 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$63	2	-97.3%	Shares	Defined	2026-08-14
2026-03-31	$17	75	-99.4%	Shares	Defined	2026-05-15
2023-12-31	$32,892	12,460	+20.7%	Shares	Defined	2024-02-14
2023-09-30	$23,741	10,323	+381.3%	Shares	Defined	2023-11-14
2023-06-30	$7,828	2,145	+879.5%	Shares	Defined	2023-08-14
2022-09-30	$488	219	+995.0%	Shares	Defined	2022-11-14
2022-06-30	$49	20	-99.2%	Shares	Defined	2022-08-15
2022-03-31	$12,980	2,660	-60.3%	Shares	Defined	2022-05-16
2021-12-31	$75,764	6,699	+135.0%	Shares	Defined	2022-02-14
2021-09-30	$41,537	2,851	+39.8%	Shares	Defined	2021-11-15
2021-06-30	$23,754	2,039	+904.4%	Shares	Sole	2021-08-16
2020-12-31	$2,539	203	+322.9%	Shares	Defined	2021-02-16
2020-09-30	$722	48	+17.1%	Shares	Defined	2020-11-16
2020-06-30	$1,004	41	-62.7%	Shares	Defined	2020-08-14
2020-03-31	$1,560	110	—	Shares	Defined	2020-06-16
No filing history on record for this holder in this stock.